KLK3 and posterior cortical atrophy: Despite the development of effective screening methods, such as the prostate-specific antigen (PSA) test, the specificity and sensitivity of current diagnostic tests for PCa are still suboptimal, leading to high rates of false-positive and false-negative results [3].